Concord Biotech Limited (BOM:543960)

Concord Biotech Revenue

Concord Biotech had revenue of 2.47B INR in the quarter ending September 30, 2025, a decrease of -20.35%. This brings the company's revenue in the last twelve months to 11.25B, up 3.63% year-over-year. In the fiscal year ending March 31, 2025, Concord Biotech had annual revenue of 12.00B with 18.01% growth.

• Revenue (ttm): 11.25B
• Revenue Growth: +3.63%
• P/S Ratio: 11.74
• Revenue / Employee: 7.16M
• Employees: 1,571
• Market Cap: 132.14B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	12.00B	1.83B	18.01%
Mar 31, 2024	10.17B	1.64B	19.20%
Mar 31, 2023	8.53B	1.40B	19.67%
Mar 31, 2022	7.13B	959.91M	15.56%
Mar 31, 2021	6.17B	1.05B	20.42%